Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
08/04/2011 | CA2788546A1 Method and device for producing 99mtc |
08/04/2011 | CA2786655A1 Radioimmunoconjugates that blind human cd37 and uses thereof |
08/03/2011 | EP2351758A1 Metal complexes, a method for preparing same, radiopharmaceutical means based thereon |
08/03/2011 | EP2350000A1 Piperazine derivatives for binding and imaging amyloid plaques and their use |
08/03/2011 | EP2349352A1 Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazinoý4,5-b¨indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
08/03/2011 | EP2349351A2 Imaging and radiotherapy methods |
08/02/2011 | US7989649 Tumor imaging compounds |
08/02/2011 | US7989589 Compstatin analogs with improved activity |
08/02/2011 | US7989417 Linkers for radiopharmaceutical compounds |
08/02/2011 | US7989415 Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome |
08/02/2011 | US7989414 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
08/02/2011 | US7988969 Treatment for central nervous system disorders |
08/02/2011 | US7988949 Nanoparticles for protein drug delivery |
08/02/2011 | US7988612 Carrier-free 103Pd brachytherapy seeds |
08/02/2011 | CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
08/02/2011 | CA2419420C Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
07/28/2011 | WO2011091113A2 Detection of early-stage pancreatic adenocarcinoma |
07/28/2011 | WO2011090492A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r) |
07/28/2011 | US20110184418 Unsealed, Non-Colloidal Radiopharmaceutical Compositions and Methods for Treatment of Abnormal Tissue |
07/28/2011 | US20110184330 Inactivation of smooth muscle tissue |
07/28/2011 | US20110184019 Long chain N-Alkyl compounds and oxa-derivatives thereof |
07/28/2011 | US20110183416 Method of modulating the proliferation of medullary thyroid carcinoma cells |
07/28/2011 | US20110182812 Imaging Agents for Detecting Neurological Disorders |
07/28/2011 | US20110182811 Nucleotide sequence encoding a modulator of nf-kb |
07/28/2011 | US20110182810 Central nervous system labelling composition for intranasal administration and labelling method and screening method using central nervous system labelling composition for intranasal administration |
07/28/2011 | US20110182809 Method of Promoting Neurogenesis |
07/28/2011 | US20110182808 Strontium-82/Rubidium-82 Generator, Method for Producing a Rubidium-82 Comprising Diagnostic Agent, Said Diagnostic Agent and Its Use in Medicine |
07/28/2011 | US20110182807 Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent |
07/28/2011 | US20110182806 Systems and methods for particle radiation enhanced delivery of therapy |
07/28/2011 | US20110182805 Nanoparticle fabrication methods, systems, and materials |
07/28/2011 | CA2787753A1 Detection of early-stage pancreatic adenocarcinoma |
07/28/2011 | CA2787074A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r) |
07/27/2011 | EP2348052A2 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
07/27/2011 | EP2348037A1 Method for introducing dota |
07/27/2011 | EP2347771A1 Peptide-based compounds for targeted imaging |
07/27/2011 | EP2347770A2 Process for producing an injectable pharmaceutical preparation |
07/27/2011 | EP1587550B1 Methods and compositions for administering therapeutic and diagnostic agents |
07/27/2011 | EP1569690B1 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
07/27/2011 | CN102137849A Cyclic polyamines for binding phosphatidylserine |
07/27/2011 | CN102133410A Immunotherapy of B cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins |
07/26/2011 | US7985836 Antimicrobial peptides and methods of identifying the same |
07/26/2011 | US7985835 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
07/26/2011 | US7985425 Non-pharmacological method for treating depression, skin disorders and improving overall health and wellness |
07/26/2011 | US7985401 Peptides whose uptake by cells is controllable |
07/26/2011 | CA2485385C Lyophilized edible food incorporating a marker |
07/26/2011 | CA2479514C Tumor imaging compounds |
07/21/2011 | WO2011087823A1 Aldehydes for in vivo imaging of aldh in cancer stem cells |
07/21/2011 | WO2011028935A3 Methods of treating mitochondrial disorders using metalloporhyrins |
07/21/2011 | WO2010121153A3 Biocompatible microbubbles to deliver radioactive compounds to tumors, atherosclerotic plaques, joints and other targeted sites |
07/21/2011 | US20110177008 Paramagnetic metal-nanodiamond conjugates |
07/21/2011 | US20110176998 Imaging and therapy of virus-associated tumors |
07/21/2011 | US20110176997 Method to make porous materials and their applications |
07/21/2011 | US20110176996 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
07/21/2011 | US20110176995 Diagnosis and treatment of cancer using anti-gpr49 antibody |
07/21/2011 | US20110176994 Buoyant Polymer Particles for Delivery of Therapeutic Agents to the Central Nervous System |
07/21/2011 | US20110176993 Vegf polymorphisms and anti-angiogenesis therapy |
07/20/2011 | EP2345673A1 Humanized anti-granulocyte MN-3 antibody and uses thereof |
07/20/2011 | EP2344040A1 Molecular imaging |
07/20/2011 | CN102126985A 18F labelled precursor compound and preparation method and application thereof |
07/20/2011 | CN101775039B Preparation method and application of 99mTc-marked hydrazino nicotinamide-folate complexs |
07/20/2011 | CN101505803B Composition for diagnosing amyloid-related disease |
07/20/2011 | CN101484190B Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
07/20/2011 | CN101301496B Biodegradable and absorbable polymer superfine fibre film with radioactive nuclide marker and preparation and use thereof |
07/20/2011 | CN101210016B Heterocycle-fused morphinans compounds, preparation method and use thereof |
07/20/2011 | CA2782658A1 Improved biomarker generator |
07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
07/19/2011 | US7981858 Methods of using zinc containing compounds to improve ocular health |
07/19/2011 | CA2188560C Compositions comprising dna damaging agents and p53 |
07/14/2011 | WO2011084571A2 Azide derivatives for phototherapy |
07/14/2011 | WO2011083845A1 Targeting agent for tumor site |
07/14/2011 | US20110172157 Somatostatin analogues |
07/14/2011 | US20110172139 Peptides whose uptake by cells is controllable |
07/14/2011 | US20110171130 A3 adenosine receptor antagonists and partial agonists |
07/14/2011 | US20110171129 Molecular Probe Precursor for Imaging of Pancreatic Islet, and Use Thereof |
07/14/2011 | US20110171128 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
07/14/2011 | US20110171126 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma |
07/14/2011 | US20110171125 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
07/14/2011 | US20110171124 In situ methods for monitoring the EMT status of tumor cells in vivo |
07/14/2011 | US20110171123 In Vivo Biofilm Infection Diagnosis and Treatment |
07/14/2011 | US20110171122 Methods and compositions for the detection of cancer |
07/13/2011 | EP2343047A2 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
07/13/2011 | EP2342197A1 Radiolabelled inhibitors of the glycine 1 transporter |
07/13/2011 | EP2341945A2 Methods and therapies for treating inflammatory conditions with exposed collagen |
07/13/2011 | EP2341944A2 Conjugates of hexose and metal coordinating compounds for imaging purposes |
07/13/2011 | EP2341909A1 Novel substituted azabenzoxazoles |
07/13/2011 | EP1828247B1 Binding molecules capable of neutralizing west nile virus and uses thereof |
07/13/2011 | CN1871233B Novel chelating agents and chelates and their use |
07/13/2011 | CN102123739A Improved methods and compositions for F-18 labeling of proteins, peptides and other molecules |
07/13/2011 | CN102120039A Use of carbon-11 marked N-methyldopamine hydrochloride in preparation of positron medicinal imaging agent |
07/13/2011 | CN101347626B Vascularized specific polypeptide for marking tumor by radioactive nucleus and uses thereof |
07/12/2011 | US7977373 Prodrugs of ion channel modulating compounds and uses thereof |
07/12/2011 | US7976855 Metal ion modified high surface area materials for odor removal and control |
07/12/2011 | US7976824 Production of 2-18F-2-deoxy-D-glucose via solid-phase synthesis |
07/12/2011 | US7976823 Ferromagnetic particles and methods |
07/12/2011 | US7976743 drug deliverying nitric oxide containing liposomes for hyperplasia, atherosclerosis; drug conjugated with antibody for drug target at specific cells; delivery rosiglitazone; reduce side effect; freezing under pressure |
07/12/2011 | CA2555435C Alpha-emitting hydroxyapatite particles |
07/07/2011 | WO2011082345A2 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
07/07/2011 | US20110166320 Somatostatin analogues |
07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |